person
as of 2026-07-01Scott W. Woods, MD
Scott W Woods, MD
ORCID 0000-0002-3103-5228
at a glance
Roles: Principal Investigator, Author, Investigator+Author
KOL signal score 8
1 publications · 1 high-value
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Yale University
Roles
Principal Investigator, Author, Investigator+Author
KOL signal
8
Publications
1 (1 high-value)
Trial investigator
yes
Trials led
9
Glycine Treatment of Prodromal Symptoms
NCT00268749Phase 2Completed
Enhancing the Prospective Prediction of Psychosis
NCT00291200—Completed
Aripiprazole Treatment of Prodromal Patients
NCT00237874Phase 2, Phase 3Completed
Ethyl-EPA Treatment of Prodromal Patients
NCT00634361Phase 2, Phase 3Completed
Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia
NCT00237861Phase 4Completed
Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics
NCT00224276—Completed
Ziprasidone in the Psychosis Prodrome
NCT00635700Phase 2Completed
Glycine vs Placebo for the Schizophrenia Prodrome
NCT00291226Phase 2, Phase 3Completed
Huperzine for Cognitive and Functional Impairment in Schizophrenia
NCT00963846Phase 2Completed
Publications & congress
1
Guidelines for the prevention of psychosis from the World Federation of Societies of Biological Psychiatry (WFSBP) and EPI Canada.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2026 · high-value
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
PRINCIPAL_INVESTIGATOR